These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35278248)

  • 1. Human adenovirus type 26 basic biology and its usage as vaccine vector.
    Majhen D
    Rev Med Virol; 2022 Nov; 32(6):e2338. PubMed ID: 35278248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
    Wang X; Kerkmann L; Hetzel M; Windmann S; Trilling M; Zhang W; Ehrhardt A; Bayer W
    J Virol; 2022 Nov; 96(22):e0113322. PubMed ID: 36342295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus vector-based vaccine for infectious diseases.
    Sakurai F; Tachibana M; Mizuguchi H
    Drug Metab Pharmacokinet; 2022 Feb; 42():100432. PubMed ID: 34974335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
    Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
    Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of 65 years of human adenovirus seroprevalence.
    Mennechet FJD; Paris O; Ouoba AR; Salazar Arenas S; Sirima SB; Takoudjou Dzomo GR; Diarra A; Traore IT; Kania D; Eichholz K; Weaver EA; Tuaillon E; Kremer EJ
    Expert Rev Vaccines; 2019 Jun; 18(6):597-613. PubMed ID: 31132024
    [No Abstract]   [Full Text] [Related]  

  • 6. Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
    Duffy MR; Alonso-Padilla J; John L; Chandra N; Khan S; Ballmann MZ; Lipiec A; Heemskerk E; Custers J; Arnberg N; Havenga M; Baker AH; Lemckert A
    J Gen Virol; 2018 Jan; 99(1):135-147. PubMed ID: 29154744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
    Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
    J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
    Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
    J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
    Dicks MD; Guzman E; Spencer AJ; Gilbert SC; Charleston B; Hill AV; Cottingham MG
    Vaccine; 2015 Feb; 33(9):1121-8. PubMed ID: 25629523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Adenovirus Type 26 Infection Mediated by αvβ3 Integrin Is Caveolin-1-Dependent.
    Nestić D; Custers J; Švec D; Majhen D
    Microbiol Spectr; 2022 Aug; 10(4):e0109722. PubMed ID: 35924932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
    Dicks MD; Spencer AJ; Edwards NJ; Wadell G; Bojang K; Gilbert SC; Hill AV; Cottingham MG
    PLoS One; 2012; 7(7):e40385. PubMed ID: 22808149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
    Doerfler W
    Virus Res; 2021 Sep; 302():198466. PubMed ID: 34087261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine.
    Sallard E; Zhang W; Aydin M; Schröer K; Ehrhardt A
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fiber Knob Protein of Human Adenovirus Type 49 Mediates Highly Efficient and Promiscuous Infection of Cancer Cell Lines Using a Novel Cell Entry Mechanism.
    Baker AT; Davies JA; Bates EA; Moses E; Mundy RM; Marlow G; Cole DK; Bliss CM; Rizkallah PJ; Parker AL
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33268514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines.
    Coughlan L
    Front Immunol; 2020; 11():909. PubMed ID: 32508823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
    Sayedahmed EE; Kumari R; Shukla S; Hassan AO; Mohammed SI; York IA; Gangappa S; Sambhara S; Mittal SK
    Vaccine; 2018 Oct; 36(45):6744-6751. PubMed ID: 30266488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector".
    Yan Y; Jing S; Feng L; Zhang J; Zeng Z; Li M; Zhao S; Ou J; Lan W; Guan W; Wu X; Wu J; Seto D; Zhang Q
    Virol Sin; 2021 Jun; 36(3):354-364. PubMed ID: 32458297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor.
    Baker AT; Mundy RM; Davies JA; Rizkallah PJ; Parker AL
    Sci Adv; 2019 Sep; 5(9):eaax3567. PubMed ID: 31517055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26.
    Nestić D; Uil TG; Ma J; Roy S; Vellinga J; Baker AH; Custers J; Majhen D
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.